Nomura Asset Management CO LTD Aeglea Bio Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

11 transactions

Quarter	Operation	Price Per share
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.81 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$0.38 - $0.81 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$0.38 - $0.81 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$0.5 - $2.66 $0 - $0
Q1 2022 May 13, 2022	BUY	$1.87 - $4.77 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$3.5 - $8.42 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$6.03 - $7.95 $0 - $0
Q2 2021 Aug 06, 2021	BUY	$6.32 - $8.38 $0 - $0
Q1 2021 May 14, 2021	BUY	$6.76 - $8.57 $0 - $0
Q4 2020 Feb 12, 2021	BUY	$7.02 - $9.83 $0 - $0
Q3 2020 Nov 12, 2020	BUY	$6.51 - $9.33 $0 - $0

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.